J. Carratala et al., BACTEREMIA DUE TO VIRIDANS STREPTOCOCCI THAT ARE HIGHLY RESISTANT TO PENICILLIN - INCREASE AMONG NEUTROPENIC PATIENTS WITH CANCER, Clinical infectious diseases, 20(5), 1995, pp. 1169-1173
We prospectively studied 260 episodes of bacteremia that occurred over
a 6-year period in neutropenic patients with cancer, Twenty-three epi
sodes were caused by viridans streptococci. Thirteen (57%) of these st
rains were penicillin-resistant (MICs of penicillin ranged from 0.25 m
u g/mL to 8 mu g/mL). Ten of the 13 penicillin-resistant strains (77%)
were highly resistant to penicillin (MIC, greater than or equal to 4
mu g/mL). Rates of bacteremia due to highly penicillin-resistant virid
ans streptococci increased significantly from zero episodes per 1,000
admissions in 1987 to 17 episodes per 1,000 admissions in 1992 (P = .0
03), In a comparison between penicillin-resistant and penicillin-susce
ptible viridans streptococci bacteremia, the administration of beta-la
ctam antibiotics during the previous 2 weeks was the only factor signi
ficantly associated with penicillin-resistant eases: 9 (69%) of 13 pat
ients with penicillin-resistant bacteremia had received beta-lactams v
s, 2 (20%) of 10 patients with penicillin-susceptible bacteremia (P =
.036). These findings may have significant clinical implications in th
e choice of both antimicrobial prophylaxis and empirical antibiotic re
gimens.